Immunohistochemical Expression of Vascular Endothelial Growth Factor in Canine Mammary Tumours

Journal of Comparative Pathology

Volumn 143, Issue 4, 2010, Pages 268-275

  Santos, A A F ^a   Oliveira, J T ^a   Lopes, C C C ^a   Amorim, I F ^a   Vicente, C M F B ^a   Gartner F R M ^a   Matos, A J F ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Dog; Immunohistochemistry; Mammary tumour; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANINE MAMMARY TUMOR; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE FIXATION; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; ADENOMA; ANIMAL; CARCINOMA; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; WESTERN BLOTTING;

CANIS FAMILIARIS;

ADENOMA; ANIMALS; BLOTTING, WESTERN; CARCINOMA; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79951919682     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.04.006     Document Type: Article

References (30)

1. Agresti A. Inference for contigency tables. Categorical Data Analysis 2002, Wiley, Hoboken, pp. 27, 91-97, 369-373. 2nd Edit. D.J. Balding, P. Bloomfield, N.A.C. Cressie (Eds.).
2. Al-Dissi A.N., Haines D.M., Singh B., Kidney B.A. Immunohistochemical expression of vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas. Veterinary Pathology 2007, 44:823-830.
3. Al-Harris E.S., Al-Janabi A.A., Al-Toriahi K.M., Yasseen A.A. Overexpression of vascular endothelial growth factor in correlation to Ki-67, grade, and stage of breast cancer. Saudi Medical Journal 2008, 29:1099-1104.
4. Dickinson P.J., Sturges B.K., Higgins R.J., Roberts B.N., Leutenegger C.M., et al. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. Veterinary Pathology 2008, 45:131-139.
5. Elston C.W., Ellis I.O. Assessment of histological grade. Rosen's Breast Pathology 1998, 365-382. Lippincott-Raven, Philadelphia. P.P. Rosen (Ed.).
6. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004, 25:581-611.
7. Folkman J., Watson K., Ingber D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61.
8. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000, 5:S37-S44.
9. Granato A.M., Nanni O., Falcini F., Folli S., Mosconi G., et al. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?. Breast Cancer Research 2004, 6:38-45.
10. Hyder S.M. Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocrine-Related Cancer 2006, 13:667-687.
11. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
12. Karayannopoulou M., Kaldrymidou E., Constantinidis T.C., Dessiris A. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. Journal of Comparative Pathology 2005, 133:1-7.
13. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis and imbalance of positive and negative regulation. Cell 1991, 64:327-336.
14. Longatto Filho A., Costa S.M., Milanezi F., Montrucoli D., Montrucoli G.C., et al. Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast: sampling assisted by dynamic angiothermography. Oncology Reports 2007, 18:1201-1206.
15. Matos A.J.F., Faustino A.M.R., Lopes C., Rutteman G.R., Gärtner F. Detection of lymph node micrometastases in canine malignant mammary tumours with the use of cytokeratin immunostaining. Veterinary Record 2006, 158:626-629.
16. Matos A.J.F., Lopes C., Carvalheira J., Santos M., Rutteman G.R., et al. E-cadherin expression in canine malignant mammary tumours: relationship to other clinicopathological variables. Journal of Comparative Pathology 2006, 134:182-189.
17. Matos A.J.F., Lopes C., Faustino A.M.R., Carvalheira J., Santos M., et al. MIB-1 indices according to clinicopathological variables in canine mammary tumours: a multivariate study. Anticancer Research 2006, 26:1821-1826.
18. Millanta F., Silvestri G., Vaselli C., Citi S., Pisani G., et al. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Research in Veterinary Science 2006, 81:350-357.
19. Misdorp W., Else R.W., Helmén E., Lipscomb T.P. Histological classification of the mammary tumours of the dog and the cat. Second Series 1999, Vol. 7:16-29. Armed Forces Institute of Pathology, Washington DC. F. Shulman (Ed.).
20. Mylona E., Alexandrou P., Giannopoulou I., Liapis G., Markaki S., et al. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma. Gynecologic Oncology 2007, 104:557-563.
21. Nieto Y., Woods J., Nawaz F., Baron A., Jones R.B., et al. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. British Journal of Cancer 2007, 97:391-397.
22. Obermair A., Kucera E., Mayerhofer K., Speiser P., Seifert M., et al. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. International Journal of Cancer 1997, 74:455-458.
23. Paku S., Paweletz N. First step of tumor related angiogenesis. Laboratory Investigation 1991, 65:334-346.
24. Pavlakis K., Messini I., Vrekoussis T., Yiannou P., Keramopoullos D., et al. The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions. BMC Cancer 2008, 8:88.
25. Qiu C.W., Lin D.G., Li C.Y., Deng G.Z. Expression and significance of PTEN and VEGF in canine mammary gland tumours. Veterinary Research Communications 2008, 32:463-472.
26. Restucci B., Papparella S., Maiolino P., De Vico G. Expression of vascular endothelial growth factor in canine mammary tumors. Veterinary Pathology 2002, 39:488-493.
27. Rutteman G.R., Lana S.E., Withrow S.J. Tumors of the mammary gland. Small Animal Clinical Oncology 2007, 619-636. Saunders Elsevier, St Louis. 4th Edit. S.J. Withrow, E.G. MacEwen (Eds.).
28. Schoeffner D.J., Matheny S.L., Akahane T., Berry A., Merlino G., et al. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Laboratory Investigation 2005, 85:608-623.
29. Sorenmo K. Canine mammary gland tumors. Veterinary Clinics of North America: Small Animal Practice 2003, 33:573-596.
30. Valkovic T., Dobrila F., Melato M., Sasso F., Rizzardi C., et al. Correlation between vascular endothelial growth factor, angiogenesis, and tumor associated macrophages in invasive ductal breast carcinoma. Virchows Archive 2002, 440:583-588.